ARTELO BIOSCIENCES, INC. Stock-Based Compensation
ARTELO BIOSCIENCES, INC. (ARTL) reported Stock-Based Compensation of $971.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-12
- ARTELO BIOSCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $570.00K, a 280.00% increase year-over-year.
- ARTELO BIOSCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $401.00K, a 108.85% increase year-over-year.
- ARTELO BIOSCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $368.00K, a 83.08% increase year-over-year.
- ARTELO BIOSCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $432.00K, a 106.70% increase year-over-year.
- ARTELO BIOSCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $2.46M.
- ARTELO BIOSCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2021 was $1.53M, a 301.84% increase from fiscal 2020.
- ARTELO BIOSCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2020 was $381.00K, a 10.38% decline from fiscal 2019.
- ARTELO BIOSCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2019 was $425.11K, a 46.59% increase from fiscal 2018.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 4 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $570.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $971.00K 10-Q · filed 2026-08-12 | $1.34M derived: sum of 3 quarters · filed 2026-08-12 | $1.77M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $401.00K 10-Q · filed 2026-05-14 | $769.00K derived: sum of 2 quarters · filed 2026-05-14 | $1.20M derived: sum of 3 quarters · filed 2026-05-14 | $1.35M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2025-12-31 | $368.00K derived: 8-K 12 month − 10-Q 9 month · filed 2026-03-17 | $800.00K derived: sum of 2 quarters · filed 2026-03-17 | $950.00K derived: sum of 3 quarters · filed 2026-03-17 | $1.14M 8-K · filed 2026-03-17 | ||||
| 2025-09-30 | $432.00K 10-Q · filed 2025-11-12 | $582.00K derived: sum of 2 quarters · filed 2025-11-12 | $774.00K 10-Q · filed 2025-11-12 | $975.00K derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2025-06-30 | $150.00K 10-Q · filed 2025-11-12 | $342.00K 10-Q · filed 2026-08-12 | $543.00K derived: sum of 3 quarters · filed 2026-05-14 | $752.00K derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2025-03-31 | $192.00K 10-Q · filed 2026-05-14 | $393.00K derived: sum of 2 quarters · filed 2026-05-14 | $602.00K derived: sum of 3 quarters · filed 2026-05-14 | $797.00K derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $201.00K derived: 8-K 12 month − 10-Q 9 month · filed 2026-03-17 | $410.00K derived: sum of 2 quarters · filed 2026-03-17 | $605.00K derived: sum of 3 quarters · filed 2026-03-17 | $818.00K 8-K · filed 2026-03-17 | ||||
| 2024-09-30 | $209.00K 10-Q · filed 2025-11-12 | $404.00K derived: sum of 2 quarters · filed 2025-11-12 | $617.00K 10-Q · filed 2025-11-12 | $836.00K derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $195.00K 10-Q · filed 2025-11-12 | $408.00K 10-Q · filed 2025-08-13 | $627.00K derived: sum of 3 quarters · filed 2025-11-12 | $849.00K derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-03-31 | $213.00K 10-Q · filed 2025-11-12 | $432.00K derived: sum of 2 quarters · filed 2025-11-12 | $654.00K derived: sum of 3 quarters · filed 2025-11-12 | $879.00K derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2023-12-31 | $219.00K derived: 8-K 12 month − 10-Q 9 month · filed 2025-07-11 | $441.00K derived: sum of 2 quarters · filed 2025-07-11 | $666.00K derived: sum of 3 quarters · filed 2025-07-11 | $1.02M 8-K · filed 2025-07-11 | ||||
| 2023-09-30 | $222.00K 10-Q · filed 2024-11-12 | $447.00K derived: sum of 2 quarters · filed 2024-11-12 | $801.00K 10-Q · filed 2024-11-12 | $1.41M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $225.00K 10-Q · filed 2024-11-12 | $579.00K 10-Q · filed 2024-08-13 | $1.19M derived: sum of 3 quarters · filed 2024-11-12 | $1.79M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-03-31 | $354.00K 10-Q · filed 2024-11-12 | $962.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.57M derived: sum of 3 quarters · filed 2024-11-12 | $2.19M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2022-12-31 | $608.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $1.22M derived: sum of 2 quarters · filed 2024-03-25 | $1.83M derived: sum of 3 quarters · filed 2024-03-25 | $2.46M 10-K · filed 2024-03-25 | ||||
| 2022-09-30 | $607.00K 10-Q · filed 2023-11-13 | $1.23M derived: sum of 2 quarters · filed 2023-11-13 | $1.85M 10-Q · filed 2023-11-13 | |||||
| 2022-06-30 | $619.00K 10-Q · filed 2023-11-13 | $1.24M 10-Q · filed 2023-08-10 | $1.20K 10-Q · filed 2022-08-09 | |||||
| 2022-03-31 | $624.00K 10-Q · filed 2023-11-13 | |||||||
| 2021-12-31 | $934.00K 10-K · filed 2023-03-31 | |||||||
| 2021-11-30 | $571.00K 10-Q · filed 2022-01-12 | |||||||
| 2021-09-30 | $502.00K 10-Q · filed 2022-11-08 | |||||||
| 2021-08-31 | $519.83K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.53M 10-K · filed 2023-03-31 | ||||||
| 2021-06-30 | $609.00K 10-Q · filed 2022-11-08 | |||||||
| 2021-05-31 | $618.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-12 | $1.01M 10-Q · filed 2021-07-12 | ||||||
| 2021-03-31 | $519.00K 10-Q · filed 2022-11-08 | |||||||
| 2021-02-28 | $341.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-13 | $392.82K 10-Q · filed 2021-04-13 | $447.42K derived: sum of 3 quarters · filed 2022-03-21 | $500.40K derived: sum of 4 quarters · filed 2022-03-21 | ||||
| 2020-12-31 | $70.00K 10-KT · filed 2022-03-21 | |||||||
| 2020-11-30 | $51.00K 10-Q · filed 2022-01-12 | $51.37K 10-Q · filed 2021-01-14 | $105.60K derived: sum of 2 quarters · filed 2022-03-21 | $158.58K derived: sum of 3 quarters · filed 2022-03-21 | $263.98K derived: sum of 4 quarters · filed 2022-03-21 | |||
| 2020-08-31 | $54.60K derived: 10-KT 12 month − 10-Q 9 month · filed 2022-03-21 | $107.58K derived: sum of 2 quarters · filed 2022-03-21 | $212.98K derived: sum of 3 quarters · filed 2022-03-21 | $381.00K 10-KT · filed 2022-03-21 | $377.77K 10-K · filed 2020-11-04 | |||
| 2020-05-31 | $52.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-12 | $158.38K derived: sum of 2 quarters · filed 2021-07-12 | $326.40K 10-Q · filed 2021-07-12 | $375.41K derived: sum of 4 quarters · filed 2021-07-12 | ||||
| 2020-02-29 | $105.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-13 | $273.42K 10-Q · filed 2021-04-13 | $322.43K derived: sum of 3 quarters · filed 2021-04-13 | $615.17K derived: sum of 4 quarters · filed 2021-04-13 | ||||
| 2019-11-30 | $168.02K 10-Q · filed 2021-01-14 | $217.03K derived: sum of 2 quarters · filed 2021-01-14 | $509.77K derived: sum of 3 quarters · filed 2021-01-14 | $552.08K derived: sum of 4 quarters · filed 2021-01-14 | ||||
| 2019-08-31 | $49.02K derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-04 | $341.75K derived: sum of 2 quarters · filed 2020-11-04 | $384.06K derived: sum of 3 quarters · filed 2020-11-04 | $425.11K 10-K · filed 2020-11-04 | ||||
| 2019-05-31 | $292.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-07-13 | $335.04K derived: sum of 2 quarters · filed 2020-07-13 | $376.10K 10-Q · filed 2020-07-13 | $497.35K derived: sum of 4 quarters · filed 2020-07-13 | ||||
| 2019-02-28 | $42.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-13 | $83.36K 10-Q · filed 2020-04-13 | $204.61K derived: sum of 3 quarters · filed 2020-04-13 | $217.36K derived: sum of 4 quarters · filed 2020-04-13 | ||||
| 2018-11-30 | $41.05K 10-Q · filed 2020-01-14 | $162.30K derived: sum of 2 quarters · filed 2020-01-14 | $175.05K derived: sum of 3 quarters · filed 2020-01-14 | $313.80K derived: sum of 4 quarters · filed 2020-01-14 | ||||
| 2018-08-31 | $121.25K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-18 | $134.00K derived: sum of 2 quarters · filed 2019-12-18 | $272.75K derived: sum of 3 quarters · filed 2019-12-18 | $290.00K 10-K/A · filed 2019-12-18 | ||||
| 2018-05-31 | $12.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-15 | $151.50K derived: sum of 2 quarters · filed 2019-07-15 | $168.75K 10-Q · filed 2019-07-15 | |||||
| 2018-02-28 | $138.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-15 | $156.00K 10-Q · filed 2019-04-15 | ||||||
| 2017-11-30 | $17.25K 10-Q · filed 2019-01-14 | |||||||
| 2017-08-31 | $3.33K 10-K · filed 2018-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |